Reicin Alise's Form 4/A amendment
AmendedTectonic Therapeutic, Inc.TECX · filed Mar 5, 2026
- Accession no.
- 0001757533-26-000008
- Filed
- Mar 5, 2026
- Trade date
- Feb 11, 2026
- Filing delay
- 22 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Feb 12, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $52.8K. It was filed 22 days after the trade.
This amendment replaces 0001757533-26-000005 (filed Feb 12, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reicin AliseCIK 0001757533 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | PPurchaseAcquired | +2,500 | $21.10F1 | +$52,750 | 127,030 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.02 to $21.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
These shares are held by the Reicin-Boiarsky Family Trust (the "Trust"). The Reporting Person's spouse is a co-trustee of the Trust. Accordingly, the Reporting Person may be deemed to have shared voting and dispositive power over the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Remarks
This Form 4/A is being filed to correct the Form 4 filed with the Securities and Exchange Commission on February 12, 2026 (the "Original Filing Date"). The Reporting Person's Trust purchased the shares reported in the Form 4 filed on the Original Filing Date, not the Reporting Person directly. This Form 4 reflects the correct ownership of the Reporting Person and the Trust as of the Original Filing Date.